non-gorlin
Showing 1 - 25 of >10,000
Recurrent Basal Cell Carcinoma Trial in United States (Patidegib Topical Gel, 2%, Patidegib Topical Gel, Vehicle)
Terminated
- Recurrent Basal Cell Carcinoma
- Patidegib Topical Gel, 2%
- Patidegib Topical Gel, Vehicle
-
Apple Valley, California
- +13 more
May 25, 2021
Nevoid Basal Cell Carcinomas in Gorlin Syndrome
Enrolling by invitation
- Basal Cell Carcinoma
- Gorlin Syndrome
- Active surveillance
-
Oslo, NorwayOslo University Hospital
Jun 8, 2023
MOPDII, MOPDI, MOPDIII Trial in Wilmington
Recruiting
- MOPDII
- +5 more
-
Wilmington, DelawareNemours
Sep 26, 2022
Gorlin Syndrome Trial (Patidegib Topical Gel, Vehicle Gel)
Not yet recruiting
- Gorlin Syndrome
- Patidegib Topical Gel
- Vehicle Gel
- (no location specified)
Sep 15, 2023
Genetic Diagnosis in Congenital Cataracts
Completed
- Congenital Cataract
- Ophthalmic examination
- Whole-exome sequencing
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
Mar 12, 2023
Basal Cell Carcinoma, Locally Advanced Basal Cell Carcinoma, Metastatic Basal Cell Carcinoma Trial in Netherlands (Vismodegib,
Recruiting
- Basal Cell Carcinoma
- +10 more
-
Nijmegen, Gelderland, Netherlands
- +7 more
Jul 14, 2022
Basal Cell Nevus Syndrome Trial in Worldwide (Patidegib Topical Gel, 2%)
Terminated
- Basal Cell Nevus Syndrome
- Patidegib Topical Gel, 2%
-
Fremont, California
- +36 more
Sep 1, 2021
Anemia Trial in Saint Paul (Ferrous gluconate 325mg, Nutrition counseling)
Completed
- Anemia
- Ferrous gluconate 325mg
- Nutrition counseling
-
Saint Paul, MinnesotaMemorial Blood Centers
Aug 31, 2021
Study of Selected X-linked Disorders: Goltz Syndrome
Active, not recruiting
- Focal Dermal Hypoplasia (FDH)
- Goltz Syndrome
-
Houston, TexasBaylor College of Medicine
Feb 22, 2022
BCCs in Gorlin Syndrome Patients Trial in United Kingdom, United States (PTX-022, Vehicle comparator)
Recruiting
- BCCs in Gorlin Syndrome Patients
- PTX-022
- Vehicle comparator
-
Scottsdale, Arizona
- +15 more
May 5, 2022
Craniometaphyseal Dysplasia (CMD)
Recruiting
- Craniometaphyseal Dysplasia
-
Farmington, ConnecticutUniversity of Connecticut Health Center
Jan 24, 2022
RUBY Post-Market Registry on the Jada® System
Completed
- Postpartum Hemorrhage
- Jada® System
-
Loma Linda, California
- +15 more
Aug 18, 2022
Basal Cell Carcinoma, Basal Cell Carcinoma of Skin, Site Unspecified, Skin Cancer Trial in North Sydney (drug, procedure, other)
Recruiting
- Basal Cell Carcinoma
- +3 more
- Sonidegib
- +3 more
-
North Sydney, New South Wales, AustraliaMelanoma Institute Australia
Jun 9, 2022
Basal Cell Nevus Syndrome Trial in London, Manchester (Patidegib, Vehicle gel)
Completed
- Basal Cell Nevus Syndrome
- Patidegib
- Vehicle gel
-
London, United Kingdom
- +1 more
Jul 8, 2020
Tobacco Smoking Trial in Boston (Distress Tolerance Intervention, Working Memory Intervention, Control Informational
Completed
- Tobacco Smoking
- Distress Tolerance Intervention
- +2 more
-
Boston, MassachusettsBoston University
Jul 21, 2021
Basal Cell Nevus Syndrome Trial in Worldwide (Patidegib Topical Gel, 2%, Patidegib Topical Gel, Vehicle)
Completed
- Basal Cell Nevus Syndrome
- Patidegib Topical Gel, 2%
- Patidegib Topical Gel, Vehicle
-
Phoenix, Arizona
- +48 more
Mar 4, 2021
Coronary Artery Bypass, Myocardial Ischemia, Myocardial Infarction Trial in Karlskrona, Linköping, Örebro (Intravenous infusion
Completed
- Coronary Artery Bypass
- +3 more
- Intravenous infusion of saline
- Intravenous glutamate infusion
-
Karlskrona, Sweden
- +2 more
May 21, 2022
Quality in Clinical Routine of German HFrEF Care
Recruiting
- Heart Failure
- Heart Failure medications
-
Winsen, Lower Saxony, Germany
- +69 more
Aug 17, 2023
Brow Ptosis, Surgical Wound Trial (Dermabond, Non-Absorbable Sutures)
Not yet recruiting
- Brow Ptosis
- Surgical Wound
- Dermabond
- Non-Absorbable Sutures
- (no location specified)
Aug 8, 2023
Peri-implant Mucositis, Mucositis Oral Trial in Naples (Spermidine gel, NSMD)
Recruiting
- Peri-implant Mucositis
- Mucositis Oral
- Spermidine gel
- NSMD
-
Naples, ItalyUniversity of Naples Federico II
Jul 3, 2023
Uromonitor asBiomarker for Optimization of NMIBC Management by
Not yet recruiting
- Non-muscle-invasive Bladder Cancer
- (no location specified)
May 9, 2023
Atrial Fibrillation New Onset, Atrial Fibrillation Paroxysmal Trial in Seoul (Amiodarone, diltiazem or esmolol)
Terminated
- Atrial Fibrillation New Onset
- Atrial Fibrillation Paroxysmal
- Amiodarone, diltiazem or esmolol
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jul 10, 2023
Development of Multi-specific Antibodies Based on Immune
Not yet recruiting
- Invasive Breast Cancer
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Mar 2, 2023
Nursing Home, Dementia, Staff Trial in Morbio Inferiore (Training on non-pharmacological therapies' methodology)
Completed
- Nursing Home
- +2 more
- Training on non-pharmacological therapies' methodology
-
Morbio Inferiore, SwitzerlandFondazione Casa San Rocco
Apr 13, 2023